BeStock  
Stocks › Biotechnology › AVBP

ArriVent BioPharma AVBP

US equityMarket cap rank #3544Biotechnology
$10.52 −$0.74 (-6.57%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $10.52 0.00%
Open$11.00
Prev close$11.26
Day range$10.38 – $11.35
Volume1.05M
Market cap$544.13M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts10
Average target$28.00+166.2% vs. price
  • Buy 100%
Low $22.00Now $10.52Avg $28.00High $43.00

Recent rating changes

The last 20 actions on file set price targets from $20.00 to $30.00, averaging $25.16.

DateFirmRatingTarget
11 Nov 2026 Citi BUY $23.00
10 Nov 2026 JonesTrading BUY $22.00
10 Nov 2026 Truist Financial BUY $24.00
10 Nov 2026 Citi BUY $23.00
10 Nov 2026 H.C. Wainwright BUY $27.00
10 Nov 2026 Oppenheimer BUY $25.00
9 Nov 2026 BTIG BUY $29.00
28 Oct 2026 H.C. Wainwright BUY $27.00
27 Oct 2026 Truist Financial BUY $21.00
26 Oct 2026 BTIG BUY $29.00
26 Oct 2026 Truist Financial BUY $21.00
26 Oct 2026 Guggenheim BUY $30.00
26 Oct 2026 Oppenheimer BUY $25.00
25 Oct 2026 BTIG BUY $29.00
25 Oct 2026 Clear Street BUY –
23 Oct 2026 Citi BUY $20.00
20 Oct 2026 B. Riley Securities BUY $29.00
13 Oct 2026 H.C. Wainwright BUY $27.00
8 Oct 2026 H.C. Wainwright BUY $27.00
7 Oct 2026 Citi BUY $20.00

Discussion

No comments yet — be the first to weigh in on AVBP.

Sign in to join the discussion.

Scroll to Top